Press Releases Roche Holding AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 09:01:05 13/05/2026 pm IST			5-day change	1st Jan Change
320.00 ^CHF	-0.47%		-0.59%	-2.50%

13/05	US FDA approves BeOne's drug for a type of blood cancer	RE
13/05	Roche Holding AG - Analyst/Investor Day

30/04	Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026	BU
24/04	Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign	BU
22/04	Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD	AQ
22/04	Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS	BU
21/04	Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD	BU
21/04	CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus	BU